—

Caligan Partners LP

Q4 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    24

  • Value ($000)

    $1,214,793

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001727492
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
L
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$280.02M
23 %

8,118,892

---

ABIVAX SA

SPONSORED ADS
00370M103
$195.8M
16 %

1,451,924

R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$102.26M
8 %

1,283,900

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$100.62M
8 %

2,772,654

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$83.41M
7 %

2,298,400

put
P
PCVX

VAXCYTE INC

COM
92243G108
$78.66M
7 %

1,704,815

E
EX9

EXELIXIS INC

COM
30161Q104
$68.08M
6 %

1,553,262

A
ADMA

ADMA BIOLOGICS INC

COM
000899104
$54.95M
5 %

3,012,508

T
TNGX

TANGO THERAPEUTICS INC

COM
87583X109
$33.05M
3 %

3,729,895

I
INBX

INHIBRX BIOSCIENCES INC

COM
45720N103
$25.56M
2 %

323,565

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 24